Dr. Susan Iannaccone, MD
Claim this profileChildren's Health
Studies Duchenne Muscular Dystrophy
Studies Spastic Paraplegia
5 reported clinical trials
7 drugs studied
Area of expertise
1Duchenne Muscular Dystrophy
DMD negative
DMD positive
DMD gene mutation exons 18+ positive
2Spastic Paraplegia
AP4M1 positive
Affiliated Hospitals
Clinical Trials Susan Iannaccone, MD is currently running
Zolgensma
for Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN protein levels and a selective dysfunction of motor neurons. SMA is an autosomal recessive, early childhood disease with an incidence of 1:10,000 live births. SMA is the leading cause of infant mortality due to genetic diseases. The purpose of this registry is to assess the long term outcomes of patients with SMA in the context of advances in treatment options and also to characterize and assess long-term safety and effectiveness of OAV-101.
Recruiting1 award N/A2 criteria
Gene Therapy
for Spastic Paraplegia
This trial tests MELPIDA, a gene therapy for patients with SPG50, a severe neurological disorder. MELPIDA aims to deliver a healthy gene to nerve cells to help them function properly and slow down the disease. Gene therapy has shown positive outcomes in treating complex neurological disorders, including amyotrophic lateral sclerosis, Parkinson's disease, and others.
Recruiting1 award Phase 1 & 28 criteria
More about Susan Iannaccone, MD
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Susan Iannaccone, MD has experience with
- MELPIDA
- Zolgensma
- Prospective Observational Registry
- SRP-5051
- Placebo
- CAP-1002
Breakdown of trials Susan Iannaccone, MD has run
Duchenne Muscular Dystrophy
Spastic Paraplegia
Muscle Spasticity
Microcephaly
Muscle stiffness
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan Iannaccone, MD specialize in?
Susan Iannaccone, MD focuses on Duchenne Muscular Dystrophy and Spastic Paraplegia. In particular, much of their work with Duchenne Muscular Dystrophy has involved DMD negative patients, or patients who are DMD positive.
Is Susan Iannaccone, MD currently recruiting for clinical trials?
Yes, Susan Iannaccone, MD is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Susan Iannaccone, MD has studied deeply?
Yes, Susan Iannaccone, MD has studied treatments such as MELPIDA, Zolgensma, Prospective observational registry.
What is the best way to schedule an appointment with Susan Iannaccone, MD?
Apply for one of the trials that Susan Iannaccone, MD is conducting.
What is the office address of Susan Iannaccone, MD?
The office of Susan Iannaccone, MD is located at: Children's Health, Dallas, Texas 75207 United States. This is the address for their practice at the Children's Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.